Search
Descriptor English: ChAdOx1 nCoV-19
Descriptor Spanish: ChAdOx1 nCoV-19
Descriptor ChAdOx1 nCoV-19
Entry term(s) AZD-1222
AZD1222
Covishield
Vaxzevria
vacuna ChAdOx1 contra la COVID-19
vacuna contra la COVID de Oxford-AstraZeneca
vacuna contra la COVID-19 de AstraZeneca
vacuna contra la COVID-19 de Oxford-AstraZeneca
vacuna frente a la COVID de Oxford-AstraZeneca
vacuna frente a la COVID-19 de Oxford-AstraZeneca
Scope note: Vacuna de vector viral contra el SARS-CoV-2 desarrollada por AstraZeneca. Su vector codifica la proteína de la espícula del SARS-CoV-2.
Descriptor Portuguese: ChAdOx1 nCoV-19
Descriptor French: Vaccin ChAdOx1 nCoV-19
Entry term(s): AZD-1222
COVID-19 Vaccine, ChAdOx1
ChAdOx1 COVID 19 Vaccine
ChAdOx1 COVID-19 Vaccine
ChAdOx1 nCoV 19
Covishield
Oxford-AstraZeneca COVID Vaccine
Oxford-AstraZeneca COVID-19 Vaccine
Vaccine, ChAdOx1 COVID-19
Vaxzevria
nCoV-19, ChAdOx1
Tree number(s): D20.215.894.865.450.250.500
D20.215.894.899.085.063
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000090985
Scope note: A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Registry Number: B5S3K2V0G8
Public MeSH Note: 2022; ChAdOx1 nCoV-19 VACCINE was indexed under COVID-19 VACCINES 2021
History Note: 2022(2021)
DeCS ID: 59831
Unique ID: D000090985
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2022/04/14
ChAdOx1 nCoV-19 - Preferred
Concept UI M000747632
Scope note A viral vector vaccine against SARS-CoV-2 developed by AstraZeneca. Its vector encodes the SARS-CoV-2 Spike protein.
Preferred term ChAdOx1 nCoV-19
Entry term(s) COVID-19 Vaccine, ChAdOx1
ChAdOx1 COVID 19 Vaccine
ChAdOx1 COVID-19 Vaccine
ChAdOx1 nCoV 19
Oxford-AstraZeneca COVID Vaccine
Oxford-AstraZeneca COVID-19 Vaccine
Vaccine, ChAdOx1 COVID-19
nCoV-19, ChAdOx1
Covishield - Related but not broader or narrower
Concept UI M000742886
Preferred term Covishield
Vaxzevria - Narrower
Concept UI M000754006
Preferred term Vaxzevria



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey